Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adjuvants, Immunologic | 34 | 2024 | 1041 | 6.370 |
Why?
|
Vaccines | 28 | 2024 | 833 | 4.790 |
Why?
|
Immunity, Innate | 51 | 2024 | 3046 | 4.340 |
Why?
|
BCG Vaccine | 8 | 2022 | 371 | 4.040 |
Why?
|
Toll-Like Receptor 8 | 11 | 2024 | 100 | 3.950 |
Why?
|
Toll-Like Receptors | 28 | 2019 | 590 | 3.730 |
Why?
|
Toll-Like Receptor 7 | 8 | 2024 | 177 | 2.640 |
Why?
|
Blood Proteins | 23 | 2024 | 1172 | 2.520 |
Why?
|
Monocytes | 15 | 2024 | 2574 | 2.510 |
Why?
|
Infant, Newborn | 77 | 2024 | 26168 | 2.470 |
Why?
|
Cytokines | 37 | 2024 | 7345 | 1.970 |
Why?
|
Antimicrobial Cationic Peptides | 21 | 2018 | 355 | 1.940 |
Why?
|
Vaccination | 21 | 2024 | 3360 | 1.910 |
Why?
|
Staphylococcus epidermidis | 8 | 2020 | 122 | 1.890 |
Why?
|
Viral Vaccines | 7 | 2024 | 598 | 1.880 |
Why?
|
Fetal Blood | 13 | 2021 | 1343 | 1.740 |
Why?
|
Imidazoles | 9 | 2024 | 1178 | 1.700 |
Why?
|
Hepatitis B Vaccines | 4 | 2022 | 186 | 1.640 |
Why?
|
Pentoxifylline | 4 | 2020 | 53 | 1.520 |
Why?
|
Bell Palsy | 2 | 2021 | 39 | 1.470 |
Why?
|
Dendritic Cells | 11 | 2024 | 2730 | 1.460 |
Why?
|
Immune System | 8 | 2020 | 795 | 1.360 |
Why?
|
Immunization | 10 | 2022 | 1228 | 1.340 |
Why?
|
Quinolines | 5 | 2017 | 759 | 1.280 |
Why?
|
Respiratory Syncytial Virus, Human | 3 | 2022 | 149 | 1.250 |
Why?
|
Leukocytes, Mononuclear | 13 | 2024 | 1828 | 1.200 |
Why?
|
Immunologic Memory | 7 | 2021 | 1354 | 1.150 |
Why?
|
Endotoxins | 5 | 2013 | 521 | 1.120 |
Why?
|
Respiratory Syncytial Virus Infections | 3 | 2022 | 364 | 1.050 |
Why?
|
Leukocytes | 8 | 2019 | 2030 | 1.040 |
Why?
|
Lipopolysaccharides | 10 | 2019 | 2214 | 1.010 |
Why?
|
Bacteremia | 7 | 2015 | 979 | 0.970 |
Why?
|
Communicable Diseases | 4 | 2024 | 879 | 0.950 |
Why?
|
Infant, Premature | 8 | 2020 | 2091 | 0.940 |
Why?
|
Th1 Cells | 3 | 2024 | 1033 | 0.910 |
Why?
|
Toll-Like Receptor 2 | 5 | 2015 | 348 | 0.910 |
Why?
|
Inflammasomes | 4 | 2018 | 532 | 0.900 |
Why?
|
Aging | 8 | 2018 | 8641 | 0.900 |
Why?
|
Blood Bactericidal Activity | 8 | 2005 | 126 | 0.900 |
Why?
|
Adaptive Immunity | 5 | 2020 | 724 | 0.900 |
Why?
|
Adenosine | 4 | 2013 | 833 | 0.900 |
Why?
|
Immunization Schedule | 2 | 2020 | 225 | 0.820 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 35 | 0.810 |
Why?
|
Alkaline Phosphatase | 2 | 2017 | 865 | 0.800 |
Why?
|
Adenosine Deaminase | 4 | 2024 | 251 | 0.800 |
Why?
|
Shoulder Dislocation | 3 | 2020 | 129 | 0.790 |
Why?
|
Gentamicins | 2 | 2020 | 252 | 0.760 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2023 | 4357 | 0.750 |
Why?
|
Inflammation Mediators | 5 | 2020 | 1882 | 0.740 |
Why?
|
Shoulder Joint | 9 | 2011 | 730 | 0.740 |
Why?
|
Mandatory Programs | 1 | 2021 | 86 | 0.710 |
Why?
|
Neutrophils | 11 | 2024 | 3770 | 0.710 |
Why?
|
Anti-Inflammatory Agents | 4 | 2020 | 1799 | 0.690 |
Why?
|
Antibody Formation | 3 | 2022 | 1400 | 0.680 |
Why?
|
Humans | 191 | 2024 | 760261 | 0.680 |
Why?
|
Mass Vaccination | 1 | 2021 | 109 | 0.680 |
Why?
|
Animals, Newborn | 13 | 2020 | 2671 | 0.670 |
Why?
|
Caspase 1 | 3 | 2018 | 226 | 0.650 |
Why?
|
Antigen-Presenting Cells | 4 | 2020 | 967 | 0.650 |
Why?
|
Vancomycin | 2 | 2020 | 503 | 0.640 |
Why?
|
Staphylococcal Infections | 5 | 2020 | 1405 | 0.630 |
Why?
|
Microbial Viability | 1 | 2020 | 238 | 0.630 |
Why?
|
B-Lymphocytes | 8 | 2024 | 4739 | 0.620 |
Why?
|
Membrane Proteins | 14 | 2007 | 7854 | 0.620 |
Why?
|
Cathelicidins | 1 | 2018 | 81 | 0.610 |
Why?
|
Legionnaires' Disease | 1 | 2018 | 49 | 0.610 |
Why?
|
RNA, Bacterial | 1 | 2020 | 384 | 0.600 |
Why?
|
Legionella pneumophila | 1 | 2018 | 49 | 0.600 |
Why?
|
Immunity, Humoral | 4 | 2024 | 604 | 0.600 |
Why?
|
Disease Susceptibility | 4 | 2017 | 1791 | 0.590 |
Why?
|
Infant | 30 | 2024 | 36030 | 0.580 |
Why?
|
Bacterial Infections | 7 | 2013 | 1402 | 0.580 |
Why?
|
Shoulder Fractures | 2 | 2020 | 93 | 0.570 |
Why?
|
Mannose-Binding Lectin | 1 | 2018 | 146 | 0.570 |
Why?
|
Lectins, C-Type | 3 | 2022 | 591 | 0.560 |
Why?
|
Proteomics | 10 | 2024 | 3810 | 0.550 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2016 | 112 | 0.540 |
Why?
|
Toll-Like Receptor 4 | 6 | 2012 | 580 | 0.530 |
Why?
|
Acute-Phase Proteins | 4 | 2020 | 250 | 0.530 |
Why?
|
Hepatitis | 1 | 2018 | 231 | 0.530 |
Why?
|
Antibodies, Viral | 10 | 2024 | 3145 | 0.520 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2016 | 778 | 0.520 |
Why?
|
Animals | 64 | 2024 | 167940 | 0.520 |
Why?
|
Proteome | 5 | 2024 | 1856 | 0.520 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2018 | 226 | 0.510 |
Why?
|
Vaccines, Conjugate | 1 | 2017 | 328 | 0.500 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2011 | 238 | 0.500 |
Why?
|
Staphylococcus | 2 | 2013 | 156 | 0.500 |
Why?
|
Sepsis | 6 | 2020 | 2594 | 0.490 |
Why?
|
Immunity | 6 | 2023 | 998 | 0.490 |
Why?
|
Trachea | 2 | 2012 | 1082 | 0.490 |
Why?
|
5'-Nucleotidase | 2 | 2013 | 161 | 0.490 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 241 | 0.490 |
Why?
|
Poliovirus Vaccine, Oral | 2 | 2016 | 26 | 0.480 |
Why?
|
Membrane Glycoproteins | 9 | 2013 | 3731 | 0.480 |
Why?
|
Receptors, Immunologic | 4 | 2019 | 1434 | 0.460 |
Why?
|
Anti-Infective Agents | 6 | 2018 | 982 | 0.460 |
Why?
|
Hypersensitivity | 2 | 2021 | 1159 | 0.450 |
Why?
|
Arthroplasty, Replacement | 4 | 2005 | 310 | 0.450 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 206 | 0.440 |
Why?
|
Organophosphorus Compounds | 1 | 2014 | 202 | 0.440 |
Why?
|
Pneumococcal Vaccines | 1 | 2017 | 397 | 0.430 |
Why?
|
RNA, Messenger | 12 | 2024 | 12762 | 0.430 |
Why?
|
Candida albicans | 3 | 2022 | 378 | 0.420 |
Why?
|
Inflammation | 9 | 2022 | 10757 | 0.420 |
Why?
|
Nanoparticles | 3 | 2024 | 1938 | 0.420 |
Why?
|
Immunocompromised Host | 2 | 2011 | 857 | 0.410 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2020 | 2494 | 0.410 |
Why?
|
Pyrimidines | 1 | 2024 | 3011 | 0.400 |
Why?
|
Bacterial Vaccines | 2 | 2017 | 401 | 0.390 |
Why?
|
S100 Proteins | 1 | 2012 | 218 | 0.390 |
Why?
|
Receptors, Cell Surface | 5 | 2019 | 2825 | 0.390 |
Why?
|
Adult | 54 | 2024 | 219847 | 0.390 |
Why?
|
Clavicle | 2 | 2005 | 224 | 0.390 |
Why?
|
Bone Marrow Diseases | 1 | 2013 | 233 | 0.390 |
Why?
|
Interleukin-6 | 7 | 2023 | 3207 | 0.390 |
Why?
|
Fibromyalgia | 1 | 2016 | 398 | 0.380 |
Why?
|
Endotoxemia | 3 | 2011 | 196 | 0.380 |
Why?
|
Immunologic Factors | 2 | 2013 | 1589 | 0.370 |
Why?
|
Chemokines | 6 | 2024 | 962 | 0.370 |
Why?
|
Polymers | 2 | 2017 | 1620 | 0.370 |
Why?
|
Benzazepines | 1 | 2013 | 311 | 0.370 |
Why?
|
Th2 Cells | 1 | 2016 | 1048 | 0.360 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 129 | 0.360 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2010 | 111 | 0.360 |
Why?
|
Alum Compounds | 3 | 2016 | 32 | 0.360 |
Why?
|
Arthroscopy | 4 | 2016 | 960 | 0.360 |
Why?
|
Whooping Cough | 2 | 2022 | 85 | 0.350 |
Why?
|
Fentanyl | 2 | 2024 | 433 | 0.350 |
Why?
|
Complement System Proteins | 3 | 2020 | 782 | 0.350 |
Why?
|
United States Food and Drug Administration | 4 | 2022 | 1675 | 0.340 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4355 | 0.340 |
Why?
|
Age Factors | 17 | 2024 | 18415 | 0.340 |
Why?
|
Accessory Nerve Diseases | 1 | 2009 | 2 | 0.340 |
Why?
|
Drug Design | 2 | 2013 | 1062 | 0.340 |
Why?
|
Fluoroquinolones | 1 | 2011 | 309 | 0.340 |
Why?
|
Communicable Disease Control | 3 | 2015 | 844 | 0.340 |
Why?
|
Homeostasis | 1 | 2020 | 3305 | 0.330 |
Why?
|
Escherichia coli | 5 | 2020 | 4223 | 0.330 |
Why?
|
NF-kappa B | 5 | 2024 | 2486 | 0.330 |
Why?
|
Tuberculosis Vaccines | 1 | 2009 | 48 | 0.330 |
Why?
|
Mucous Membrane | 3 | 2008 | 657 | 0.330 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2250 | 0.330 |
Why?
|
Tuberculosis | 1 | 2022 | 2003 | 0.330 |
Why?
|
Rheumatic Diseases | 1 | 2016 | 639 | 0.330 |
Why?
|
Interleukin-12 | 3 | 2024 | 584 | 0.320 |
Why?
|
Cells, Cultured | 11 | 2020 | 18968 | 0.320 |
Why?
|
Fatigue | 1 | 2016 | 1544 | 0.320 |
Why?
|
Mice | 32 | 2024 | 81216 | 0.320 |
Why?
|
Defensins | 4 | 2002 | 34 | 0.320 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 1173 | 0.310 |
Why?
|
AIDS Vaccines | 3 | 2019 | 896 | 0.310 |
Why?
|
Energy Metabolism | 1 | 2019 | 2869 | 0.310 |
Why?
|
Cell Movement | 1 | 2020 | 5206 | 0.310 |
Why?
|
Brain Injuries | 3 | 2020 | 2044 | 0.310 |
Why?
|
Plasma | 3 | 2021 | 584 | 0.310 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4437 | 0.310 |
Why?
|
Female | 71 | 2024 | 391011 | 0.310 |
Why?
|
Gambia | 5 | 2024 | 104 | 0.310 |
Why?
|
Exercise Therapy | 2 | 2020 | 920 | 0.300 |
Why?
|
Recombinant Proteins | 8 | 2018 | 6543 | 0.300 |
Why?
|
Paralysis | 1 | 2009 | 251 | 0.290 |
Why?
|
Scapula | 1 | 2009 | 173 | 0.290 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2127 | 0.290 |
Why?
|
Vaccines, DNA | 1 | 2008 | 286 | 0.280 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 287 | 0.280 |
Why?
|
Receptor, Adenosine A3 | 1 | 2006 | 4 | 0.280 |
Why?
|
Blood Loss, Surgical | 1 | 2011 | 657 | 0.280 |
Why?
|
Attitude | 2 | 2022 | 777 | 0.280 |
Why?
|
Virus Diseases | 2 | 2013 | 721 | 0.280 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3735 | 0.280 |
Why?
|
Colony Count, Microbial | 2 | 2018 | 328 | 0.270 |
Why?
|
Hypoxia-Ischemia, Brain | 2 | 2020 | 352 | 0.270 |
Why?
|
Immunity, Cellular | 5 | 2024 | 1558 | 0.260 |
Why?
|
Male | 56 | 2024 | 359413 | 0.250 |
Why?
|
Signal Transduction | 14 | 2020 | 23363 | 0.250 |
Why?
|
Immunization Programs | 4 | 2019 | 268 | 0.250 |
Why?
|
Aluminum Hydroxide | 2 | 2022 | 54 | 0.250 |
Why?
|
Mice, Inbred C57BL | 13 | 2024 | 22025 | 0.250 |
Why?
|
Chemokine CCL2 | 2 | 2020 | 607 | 0.250 |
Why?
|
Pseudarthrosis | 1 | 2005 | 54 | 0.250 |
Why?
|
Cyclic AMP | 3 | 2019 | 1455 | 0.250 |
Why?
|
Anti-Bacterial Agents | 9 | 2020 | 7400 | 0.250 |
Why?
|
Phosphates | 2 | 2020 | 771 | 0.240 |
Why?
|
Babesiosis | 1 | 2006 | 92 | 0.240 |
Why?
|
Lipid A | 2 | 2016 | 70 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2013 | 5644 | 0.240 |
Why?
|
Aminoquinolines | 1 | 2004 | 108 | 0.240 |
Why?
|
Docosahexaenoic Acids | 1 | 2011 | 912 | 0.230 |
Why?
|
Models, Biological | 1 | 2020 | 9468 | 0.230 |
Why?
|
Radiation Injuries | 1 | 2011 | 1183 | 0.230 |
Why?
|
Immunomodulation | 3 | 2021 | 547 | 0.230 |
Why?
|
Flagellin | 2 | 2020 | 124 | 0.230 |
Why?
|
Chickenpox Vaccine | 1 | 2003 | 41 | 0.220 |
Why?
|
Breast Feeding | 2 | 2024 | 1356 | 0.220 |
Why?
|
Cross-Priming | 1 | 2024 | 75 | 0.220 |
Why?
|
Muscle, Skeletal | 2 | 2009 | 4923 | 0.220 |
Why?
|
Pain | 3 | 2022 | 5066 | 0.220 |
Why?
|
Infant, Premature, Diseases | 2 | 2007 | 708 | 0.220 |
Why?
|
Mice, Inbred BALB C | 5 | 2022 | 6226 | 0.220 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2009 | 708 | 0.220 |
Why?
|
Lipoproteins | 2 | 2006 | 882 | 0.220 |
Why?
|
Pertussis Vaccine | 2 | 2022 | 39 | 0.220 |
Why?
|
Physical Examination | 1 | 2009 | 1244 | 0.210 |
Why?
|
Biomedical Research | 1 | 2018 | 3421 | 0.210 |
Why?
|
Escherichia coli Infections | 2 | 2020 | 524 | 0.210 |
Why?
|
Herpesvirus 3, Human | 1 | 2003 | 159 | 0.210 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3758 | 0.210 |
Why?
|
West Nile Fever | 1 | 2022 | 74 | 0.210 |
Why?
|
West Nile virus | 1 | 2022 | 76 | 0.200 |
Why?
|
HIV Infections | 7 | 2023 | 17159 | 0.200 |
Why?
|
Hemagglutinins | 1 | 2022 | 113 | 0.200 |
Why?
|
Viral Fusion Proteins | 1 | 2022 | 99 | 0.200 |
Why?
|
Pregnancy | 13 | 2023 | 29725 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2024 | 1655 | 0.200 |
Why?
|
Body Fluids | 1 | 2024 | 319 | 0.200 |
Why?
|
Mannans | 1 | 2022 | 58 | 0.200 |
Why?
|
Streptococcus agalactiae | 1 | 2003 | 337 | 0.200 |
Why?
|
Immunization, Secondary | 1 | 2024 | 366 | 0.190 |
Why?
|
Proteins | 4 | 2023 | 6030 | 0.190 |
Why?
|
Antigens, Viral | 2 | 2022 | 980 | 0.190 |
Why?
|
Up-Regulation | 4 | 2020 | 4127 | 0.190 |
Why?
|
Immune Tolerance | 3 | 2012 | 2299 | 0.190 |
Why?
|
Systems Biology | 3 | 2022 | 479 | 0.190 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2024 | 15766 | 0.190 |
Why?
|
Bone Marrow | 1 | 2011 | 2918 | 0.190 |
Why?
|
Gram-Negative Bacteria | 2 | 2000 | 272 | 0.190 |
Why?
|
Macrophages | 4 | 2022 | 5745 | 0.190 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2623 | 0.190 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2002 | 173 | 0.190 |
Why?
|
Herpes Zoster | 1 | 2003 | 251 | 0.180 |
Why?
|
Humerus | 2 | 2017 | 269 | 0.180 |
Why?
|
Epithelial Cells | 5 | 2011 | 3665 | 0.180 |
Why?
|
HIV-1 | 5 | 2022 | 6850 | 0.180 |
Why?
|
Gestational Age | 3 | 2019 | 3564 | 0.180 |
Why?
|
Deltoid Muscle | 1 | 2020 | 18 | 0.180 |
Why?
|
Public-Private Sector Partnerships | 1 | 2021 | 122 | 0.180 |
Why?
|
Acyclovir | 1 | 2021 | 269 | 0.180 |
Why?
|
Bulgaria | 1 | 2020 | 17 | 0.180 |
Why?
|
DNA Methylation | 2 | 2024 | 4374 | 0.170 |
Why?
|
Severity of Illness Index | 6 | 2024 | 15827 | 0.170 |
Why?
|
Toll-Like Receptor 5 | 1 | 2020 | 42 | 0.170 |
Why?
|
Vaccines, Attenuated | 2 | 2016 | 316 | 0.170 |
Why?
|
Toll-Like Receptor 9 | 2 | 2024 | 235 | 0.170 |
Why?
|
Prosthesis Design | 4 | 2017 | 2127 | 0.170 |
Why?
|
Bottle Feeding | 1 | 2019 | 67 | 0.170 |
Why?
|
Phagocytosis | 5 | 2012 | 1536 | 0.170 |
Why?
|
Fetus | 1 | 2007 | 1859 | 0.170 |
Why?
|
Osteoarthritis | 2 | 2005 | 1055 | 0.170 |
Why?
|
Chromatography, Liquid | 3 | 2022 | 987 | 0.170 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5498 | 0.170 |
Why?
|
Education | 2 | 2019 | 535 | 0.170 |
Why?
|
Mycobacterium bovis | 1 | 2020 | 147 | 0.170 |
Why?
|
Candidiasis | 1 | 2002 | 364 | 0.160 |
Why?
|
Antibodies, Neutralizing | 4 | 2023 | 1933 | 0.160 |
Why?
|
Papua New Guinea | 3 | 2024 | 46 | 0.160 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 2 | 2010 | 76 | 0.160 |
Why?
|
Interleukin-10 | 2 | 2017 | 1174 | 0.160 |
Why?
|
Congresses as Topic | 3 | 2019 | 804 | 0.160 |
Why?
|
Virulence Factors, Bordetella | 1 | 2018 | 154 | 0.160 |
Why?
|
Adolescent | 20 | 2024 | 87747 | 0.160 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1483 | 0.160 |
Why?
|
Killer Cells, Natural | 2 | 2009 | 2204 | 0.160 |
Why?
|
Child | 15 | 2024 | 79758 | 0.160 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2018 | 42 | 0.160 |
Why?
|
United States | 9 | 2022 | 72363 | 0.160 |
Why?
|
Immunophenotyping | 2 | 2020 | 1870 | 0.160 |
Why?
|
Carrier Proteins | 3 | 2013 | 4938 | 0.160 |
Why?
|
Opioid-Related Disorders | 2 | 2024 | 2135 | 0.160 |
Why?
|
Chorioamnionitis | 1 | 2019 | 156 | 0.150 |
Why?
|
Fimbriae Proteins | 1 | 2018 | 132 | 0.150 |
Why?
|
Shoulder | 1 | 2020 | 299 | 0.150 |
Why?
|
Macaca mulatta | 2 | 2017 | 2316 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2012 | 581 | 0.150 |
Why?
|
Interdisciplinary Studies | 1 | 2018 | 86 | 0.150 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2008 | 557 | 0.150 |
Why?
|
Infant Formula | 1 | 2019 | 193 | 0.150 |
Why?
|
Child Development | 2 | 2020 | 2280 | 0.150 |
Why?
|
Blood Cells | 2 | 2015 | 305 | 0.150 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2018 | 1246 | 0.150 |
Why?
|
Flow Cytometry | 5 | 2024 | 5873 | 0.150 |
Why?
|
RNA | 1 | 2007 | 2721 | 0.150 |
Why?
|
Tissue Culture Techniques | 1 | 2018 | 290 | 0.150 |
Why?
|
Aged | 22 | 2024 | 168995 | 0.150 |
Why?
|
Denmark | 1 | 2020 | 759 | 0.150 |
Why?
|
Rosaniline Dyes | 1 | 2017 | 48 | 0.150 |
Why?
|
Fracture Fixation, Internal | 2 | 2020 | 964 | 0.140 |
Why?
|
T-Lymphocytes | 5 | 2024 | 10183 | 0.140 |
Why?
|
Immunoglobulins | 1 | 2020 | 863 | 0.140 |
Why?
|
Term Birth | 1 | 2018 | 140 | 0.140 |
Why?
|
Premature Birth | 2 | 2020 | 1771 | 0.140 |
Why?
|
Histocytochemistry | 1 | 2018 | 693 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4554 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 425 | 0.140 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2004 | 833 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2022 | 696 | 0.140 |
Why?
|
Azithromycin | 1 | 2018 | 201 | 0.140 |
Why?
|
Salmonella | 1 | 2017 | 128 | 0.140 |
Why?
|
Nutritive Value | 1 | 2019 | 349 | 0.140 |
Why?
|
Lyme Disease | 1 | 2022 | 630 | 0.140 |
Why?
|
Lymphocytes | 1 | 2024 | 2612 | 0.140 |
Why?
|
Israel | 2 | 2016 | 722 | 0.140 |
Why?
|
Drug Synergism | 2 | 2018 | 1755 | 0.140 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 441 | 0.140 |
Why?
|
Respiratory Tract Infections | 1 | 2024 | 1001 | 0.140 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 2016 | 24 | 0.140 |
Why?
|
HIV Seropositivity | 1 | 2022 | 955 | 0.130 |
Why?
|
Enzyme Assays | 1 | 2017 | 108 | 0.130 |
Why?
|
Drug Discovery | 1 | 2024 | 1056 | 0.130 |
Why?
|
Lactoferrin | 2 | 2013 | 100 | 0.130 |
Why?
|
Metabolomics | 3 | 2020 | 1626 | 0.130 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 123 | 0.130 |
Why?
|
Malaria Vaccines | 1 | 2017 | 164 | 0.130 |
Why?
|
Vaccines, Synthetic | 3 | 2024 | 617 | 0.130 |
Why?
|
Ectodermal Dysplasia | 2 | 2008 | 106 | 0.130 |
Why?
|
HIV Antibodies | 2 | 2019 | 1300 | 0.130 |
Why?
|
Range of Motion, Articular | 4 | 2008 | 1582 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2020 | 911 | 0.130 |
Why?
|
Vaccines, Inactivated | 1 | 2016 | 180 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1289 | 0.130 |
Why?
|
Biomimetics | 1 | 2017 | 173 | 0.130 |
Why?
|
Japan | 1 | 2020 | 1369 | 0.130 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2015 | 57 | 0.130 |
Why?
|
Poliomyelitis | 1 | 2016 | 95 | 0.120 |
Why?
|
Young Adult | 11 | 2024 | 58673 | 0.120 |
Why?
|
Milk, Human | 1 | 2019 | 484 | 0.120 |
Why?
|
Klebsiella pneumoniae | 1 | 2017 | 255 | 0.120 |
Why?
|
Lipoxins | 2 | 2011 | 418 | 0.120 |
Why?
|
Chemokine CXCL1 | 1 | 2015 | 107 | 0.120 |
Why?
|
Asthma | 2 | 2024 | 6167 | 0.120 |
Why?
|
Myocarditis | 1 | 2022 | 766 | 0.120 |
Why?
|
HEK293 Cells | 2 | 2015 | 4264 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 2424 | 0.120 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4546 | 0.120 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 289 | 0.120 |
Why?
|
Middle Aged | 21 | 2024 | 220175 | 0.120 |
Why?
|
Systems Analysis | 1 | 2015 | 169 | 0.120 |
Why?
|
Quality of Life | 1 | 2016 | 13300 | 0.120 |
Why?
|
Lung | 3 | 2022 | 9989 | 0.120 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2696 | 0.120 |
Why?
|
Cell Adhesion Molecules | 2 | 2011 | 1602 | 0.120 |
Why?
|
Still's Disease, Adult-Onset | 1 | 2014 | 22 | 0.120 |
Why?
|
Analysis of Variance | 2 | 2013 | 6242 | 0.110 |
Why?
|
Cell Adhesion | 1 | 2020 | 3096 | 0.110 |
Why?
|
Brain | 3 | 2020 | 26912 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2019 | 781 | 0.110 |
Why?
|
Radiography | 4 | 2013 | 6965 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1902 | 0.110 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2192 | 0.110 |
Why?
|
Pancreatectomy | 1 | 2018 | 809 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2021 | 770 | 0.110 |
Why?
|
India | 1 | 2020 | 2346 | 0.110 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2018 | 736 | 0.110 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1155 | 0.110 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 558 | 0.110 |
Why?
|
Interleukin-1beta | 2 | 2017 | 999 | 0.110 |
Why?
|
Limulus Test | 1 | 2012 | 19 | 0.110 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2015 | 343 | 0.110 |
Why?
|
Microscopy | 1 | 2018 | 881 | 0.110 |
Why?
|
Inosine | 1 | 2013 | 130 | 0.110 |
Why?
|
Caspase 3 | 1 | 2015 | 730 | 0.100 |
Why?
|
Treatment Outcome | 10 | 2020 | 64947 | 0.100 |
Why?
|
Isoenzymes | 1 | 2017 | 1690 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1899 | 0.100 |
Why?
|
Vaccines, Subunit | 1 | 2012 | 161 | 0.100 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 688 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3604 | 0.100 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6499 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 2016 | 2414 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2627 | 0.100 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2015 | 326 | 0.100 |
Why?
|
C-Reactive Protein | 1 | 2003 | 3822 | 0.100 |
Why?
|
Immunoglobulin M | 1 | 2016 | 1529 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2023 | 18134 | 0.100 |
Why?
|
Spleen | 2 | 2015 | 2298 | 0.100 |
Why?
|
Interleukins | 1 | 2016 | 782 | 0.100 |
Why?
|
Vaccines, Acellular | 2 | 2022 | 11 | 0.090 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2010 | 20 | 0.090 |
Why?
|
Drug Delivery Systems | 2 | 2020 | 2218 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 3804 | 0.090 |
Why?
|
Whole-Body Irradiation | 1 | 2011 | 433 | 0.090 |
Why?
|
Gene Expression Regulation | 4 | 2018 | 11902 | 0.090 |
Why?
|
Blood Cell Count | 1 | 2011 | 398 | 0.090 |
Why?
|
Genetic Testing | 1 | 2004 | 3530 | 0.090 |
Why?
|
Dexamethasone | 1 | 2018 | 1928 | 0.090 |
Why?
|
Lipopeptides | 2 | 2011 | 73 | 0.090 |
Why?
|
Bacteriolysis | 1 | 2010 | 51 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2016 | 10434 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2003 | 2041 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 1995 | 0.090 |
Why?
|
Receptors, IgG | 1 | 2013 | 565 | 0.090 |
Why?
|
Electromyography | 2 | 2020 | 1386 | 0.090 |
Why?
|
Injections, Intravenous | 1 | 2012 | 1388 | 0.090 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1462 | 0.090 |
Why?
|
I-kappa B Kinase | 2 | 2008 | 251 | 0.090 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 538 | 0.090 |
Why?
|
Organ Size | 2 | 2011 | 2249 | 0.080 |
Why?
|
Thoracic Nerves | 1 | 2009 | 20 | 0.080 |
Why?
|
Hip Joint | 1 | 2016 | 1006 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2016 | 2363 | 0.080 |
Why?
|
Liver | 3 | 2015 | 7512 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2023 | 3960 | 0.080 |
Why?
|
Phospholipids | 2 | 2008 | 789 | 0.080 |
Why?
|
Child, Preschool | 8 | 2024 | 42034 | 0.080 |
Why?
|
Blotting, Western | 2 | 2011 | 5039 | 0.080 |
Why?
|
Phenotype | 3 | 2024 | 16543 | 0.080 |
Why?
|
Patient Satisfaction | 2 | 2016 | 3451 | 0.080 |
Why?
|
Ablation Techniques | 1 | 2011 | 249 | 0.080 |
Why?
|
Ligands | 3 | 2022 | 3277 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2014 | 1254 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2015 | 14396 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2282 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6067 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2004 | 3763 | 0.080 |
Why?
|
Crassostrea | 1 | 2007 | 1 | 0.080 |
Why?
|
Apyrase | 1 | 2011 | 373 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 854 | 0.080 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2009 | 1351 | 0.070 |
Why?
|
Oligopeptides | 2 | 2019 | 1188 | 0.070 |
Why?
|
Sampling Studies | 1 | 2009 | 614 | 0.070 |
Why?
|
Blood | 1 | 2010 | 586 | 0.070 |
Why?
|
Organ Specificity | 1 | 2012 | 1955 | 0.070 |
Why?
|
Hematopoiesis | 2 | 2020 | 2063 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10340 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 2 | 2008 | 378 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10761 | 0.070 |
Why?
|
Adenosine A3 Receptor Antagonists | 1 | 2006 | 2 | 0.070 |
Why?
|
Antigens, CD | 2 | 2011 | 4002 | 0.070 |
Why?
|
Rupture | 1 | 2008 | 443 | 0.070 |
Why?
|
Bursa, Synovial | 1 | 2006 | 25 | 0.070 |
Why?
|
Macrophage-1 Antigen | 2 | 2006 | 286 | 0.070 |
Why?
|
Shoulder Impingement Syndrome | 1 | 2006 | 35 | 0.070 |
Why?
|
Time Factors | 4 | 2021 | 40133 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2012 | 3601 | 0.070 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14482 | 0.070 |
Why?
|
Neutropenia | 1 | 2011 | 884 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 17766 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10530 | 0.070 |
Why?
|
Babesia | 1 | 2006 | 29 | 0.070 |
Why?
|
Receptors, Virus | 1 | 2009 | 639 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6775 | 0.070 |
Why?
|
Pediatrics | 2 | 2024 | 3587 | 0.070 |
Why?
|
Neurologic Examination | 1 | 2009 | 916 | 0.070 |
Why?
|
Joint Instability | 2 | 2004 | 795 | 0.060 |
Why?
|
Thiazoles | 1 | 2013 | 1509 | 0.060 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 212 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9282 | 0.060 |
Why?
|
Models, Immunological | 1 | 2007 | 513 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41317 | 0.060 |
Why?
|
Rotator Cuff | 1 | 2008 | 342 | 0.060 |
Why?
|
Peptides | 3 | 2009 | 4358 | 0.060 |
Why?
|
Polydeoxyribonucleotides | 1 | 2006 | 138 | 0.060 |
Why?
|
Lipids | 3 | 2024 | 3336 | 0.060 |
Why?
|
Interferon Inducers | 1 | 2004 | 25 | 0.060 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2651 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3784 | 0.060 |
Why?
|
Myeloid Cells | 2 | 2007 | 821 | 0.060 |
Why?
|
Lymphocyte Subsets | 2 | 2009 | 310 | 0.060 |
Why?
|
Lymphoid Tissue | 1 | 2006 | 446 | 0.060 |
Why?
|
Interferon-gamma | 2 | 2024 | 3160 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10829 | 0.060 |
Why?
|
Pronation | 1 | 2004 | 52 | 0.060 |
Why?
|
Phosphorylation | 2 | 2006 | 8314 | 0.060 |
Why?
|
Supination | 1 | 2004 | 68 | 0.060 |
Why?
|
Muscle Strength | 1 | 2008 | 619 | 0.060 |
Why?
|
Integrin alphaXbeta2 | 1 | 2003 | 29 | 0.060 |
Why?
|
Safety | 1 | 2009 | 1149 | 0.060 |
Why?
|
Antirheumatic Agents | 1 | 2014 | 1374 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4573 | 0.060 |
Why?
|
Complement Factor B | 1 | 2003 | 72 | 0.060 |
Why?
|
Lipocalins | 1 | 2004 | 161 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2008 | 1201 | 0.060 |
Why?
|
Host-Pathogen Interactions | 3 | 2020 | 1447 | 0.050 |
Why?
|
Macrophage Activation | 1 | 2006 | 553 | 0.050 |
Why?
|
Poverty | 1 | 2015 | 2695 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15273 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2852 | 0.050 |
Why?
|
Uterus | 1 | 2007 | 651 | 0.050 |
Why?
|
Prognosis | 2 | 2024 | 29636 | 0.050 |
Why?
|
Computational Biology | 2 | 2019 | 3504 | 0.050 |
Why?
|
Equipment Design | 1 | 2011 | 3520 | 0.050 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2022 | 49 | 0.050 |
Why?
|
Dinoprostone | 2 | 2018 | 599 | 0.050 |
Why?
|
Intestinal Mucosa | 2 | 2011 | 3023 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3774 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 761 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 25928 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4168 | 0.050 |
Why?
|
Transcription Factor RelB | 1 | 2022 | 28 | 0.050 |
Why?
|
Serum | 1 | 2003 | 211 | 0.050 |
Why?
|
Bone Cements | 1 | 2004 | 324 | 0.050 |
Why?
|
Joint Prosthesis | 1 | 2004 | 253 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2441 | 0.050 |
Why?
|
Rotation | 1 | 2004 | 514 | 0.050 |
Why?
|
Weight Gain | 1 | 2012 | 2347 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2022 | 975 | 0.050 |
Why?
|
Cell Extracts | 1 | 2002 | 135 | 0.050 |
Why?
|
Pneumococcal Infections | 1 | 2006 | 503 | 0.050 |
Why?
|
Anti-Retroviral Agents | 2 | 2023 | 1780 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2424 | 0.050 |
Why?
|
Amphotericin B | 1 | 2002 | 141 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58947 | 0.050 |
Why?
|
Complement C3 | 1 | 2003 | 451 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2012 | 5201 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2009 | 1354 | 0.050 |
Why?
|
Ligaments, Articular | 1 | 2004 | 300 | 0.050 |
Why?
|
Interleukin-13 | 1 | 2023 | 371 | 0.050 |
Why?
|
beta-Glucans | 1 | 2022 | 121 | 0.050 |
Why?
|
Plant Physiological Phenomena | 1 | 2000 | 16 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 484 | 0.050 |
Why?
|
Anura | 1 | 2000 | 80 | 0.050 |
Why?
|
Mutation | 5 | 2011 | 29950 | 0.050 |
Why?
|
Humeral Head | 1 | 2020 | 41 | 0.050 |
Why?
|
Animal Experimentation | 1 | 2020 | 46 | 0.050 |
Why?
|
Liposomes | 1 | 2024 | 776 | 0.040 |
Why?
|
Sutures | 1 | 2003 | 294 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2002 | 326 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2024 | 1600 | 0.040 |
Why?
|
Prospective Studies | 5 | 2024 | 54263 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2004 | 721 | 0.040 |
Why?
|
Protein Conformation | 2 | 2009 | 3969 | 0.040 |
Why?
|
Solubility | 1 | 2022 | 1088 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2005 | 601 | 0.040 |
Why?
|
Isometric Contraction | 1 | 2020 | 146 | 0.040 |
Why?
|
Arthroplasty | 1 | 2002 | 313 | 0.040 |
Why?
|
Colitis | 1 | 2008 | 1229 | 0.040 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 8058 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2015 | 11480 | 0.040 |
Why?
|
Toll-Like Receptor 3 | 2 | 2012 | 98 | 0.040 |
Why?
|
Antibody Specificity | 1 | 2022 | 1061 | 0.040 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2805 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1221 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2020 | 214 | 0.040 |
Why?
|
Accidents, Traffic | 1 | 2005 | 814 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2022 | 3491 | 0.040 |
Why?
|
Paranasal Sinuses | 1 | 2022 | 265 | 0.040 |
Why?
|
Diglycerides | 1 | 2019 | 176 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2002 | 629 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2020 | 208 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12281 | 0.040 |
Why?
|
Reoperation | 3 | 2004 | 4292 | 0.040 |
Why?
|
Bordetella pertussis | 1 | 2018 | 45 | 0.040 |
Why?
|
Genotype | 1 | 2013 | 12959 | 0.040 |
Why?
|
Belgium | 1 | 2018 | 118 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10185 | 0.040 |
Why?
|
Troponin | 1 | 2022 | 516 | 0.040 |
Why?
|
Administration, Topical | 1 | 2000 | 697 | 0.040 |
Why?
|
Prosthesis Failure | 1 | 2004 | 1206 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7593 | 0.040 |
Why?
|
Protein Subunits | 1 | 2022 | 943 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2020 | 471 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 705 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 15687 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 1977 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2018 | 1470 | 0.040 |
Why?
|
Pandemics | 3 | 2022 | 8621 | 0.040 |
Why?
|
Aerosols | 1 | 2000 | 633 | 0.040 |
Why?
|
Placenta | 1 | 2007 | 1701 | 0.040 |
Why?
|
HLA Antigens | 1 | 2003 | 1369 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2002 | 859 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5507 | 0.040 |
Why?
|
Cell Membrane | 2 | 2004 | 3683 | 0.040 |
Why?
|
Antigens | 2 | 2016 | 1447 | 0.040 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2017 | 62 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2023 | 943 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2006 | 2536 | 0.040 |
Why?
|
Suture Techniques | 1 | 2002 | 788 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2020 | 628 | 0.040 |
Why?
|
Rabbits | 2 | 1994 | 4773 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2002 | 1833 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 908 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2007 | 1993 | 0.040 |
Why?
|
Benchmarking | 1 | 2023 | 1043 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1906 | 0.030 |
Why?
|
Immunity, Mucosal | 1 | 2020 | 481 | 0.030 |
Why?
|
DNA, Viral | 1 | 2003 | 2195 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13505 | 0.030 |
Why?
|
Bacterial Proteins | 2 | 2006 | 3822 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2007 | 2755 | 0.030 |
Why?
|
Muramidase | 1 | 1996 | 169 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2018 | 407 | 0.030 |
Why?
|
Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
Protein Binding | 3 | 2019 | 9336 | 0.030 |
Why?
|
Bone Transplantation | 1 | 2020 | 922 | 0.030 |
Why?
|
Interferon Type I | 2 | 2010 | 559 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2506 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 2002 | 1066 | 0.030 |
Why?
|
HIV | 1 | 2022 | 1579 | 0.030 |
Why?
|
France | 1 | 2016 | 511 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2022 | 9388 | 0.030 |
Why?
|
Reference Values | 1 | 2002 | 4920 | 0.030 |
Why?
|
Regeneration | 1 | 2004 | 1506 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2024 | 80301 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1870 | 0.030 |
Why?
|
Cell Separation | 1 | 1999 | 1720 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2837 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14656 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15680 | 0.030 |
Why?
|
Pain Measurement | 1 | 2004 | 3514 | 0.030 |
Why?
|
Patient Positioning | 1 | 2016 | 327 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7809 | 0.030 |
Why?
|
Caco-2 Cells | 2 | 2005 | 368 | 0.030 |
Why?
|
Drug Substitution | 1 | 2016 | 296 | 0.030 |
Why?
|
Workflow | 1 | 2018 | 851 | 0.030 |
Why?
|
Models, Molecular | 1 | 2003 | 5429 | 0.030 |
Why?
|
Phylogeny | 1 | 2000 | 2775 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2120 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1811 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1090 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2013 | 81 | 0.030 |
Why?
|
Viral Load | 1 | 2022 | 3323 | 0.030 |
Why?
|
Drug Carriers | 1 | 2017 | 706 | 0.030 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13456 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 4494 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 1190 | 0.020 |
Why?
|
Patient Selection | 1 | 2004 | 4276 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2007 | 17628 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2020 | 1894 | 0.020 |
Why?
|
Pancreatitis | 1 | 2018 | 1100 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1434 | 0.020 |
Why?
|
Carbohydrates | 1 | 2012 | 388 | 0.020 |
Why?
|
Mammals | 1 | 1996 | 1129 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2186 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1746 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3159 | 0.020 |
Why?
|
Communication | 1 | 2024 | 3846 | 0.020 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2009 | 25 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22066 | 0.020 |
Why?
|
Receptors, Interleukin-1 | 1 | 2010 | 261 | 0.020 |
Why?
|
Cell Line | 3 | 2010 | 15626 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2002 | 3061 | 0.020 |
Why?
|
Transfection | 2 | 2010 | 5782 | 0.020 |
Why?
|
Purines | 1 | 2012 | 601 | 0.020 |
Why?
|
Clusterin | 1 | 2009 | 71 | 0.020 |
Why?
|
STAT1 Transcription Factor | 1 | 2010 | 333 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1566 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 1549 | 0.020 |
Why?
|
Granulocytes | 1 | 2010 | 551 | 0.020 |
Why?
|
Ostreidae | 1 | 2007 | 3 | 0.020 |
Why?
|
Risk Factors | 2 | 2013 | 74269 | 0.020 |
Why?
|
Coagulase | 1 | 2007 | 54 | 0.020 |
Why?
|
Down-Regulation | 2 | 2006 | 2918 | 0.020 |
Why?
|
Invertebrates | 1 | 2007 | 54 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 4044 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2007 | 250 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2009 | 453 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1993 | 4172 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2008 | 915 | 0.020 |
Why?
|
K562 Cells | 1 | 2008 | 640 | 0.020 |
Why?
|
Streptolysins | 1 | 2006 | 57 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12412 | 0.020 |
Why?
|
Sp Transcription Factors | 1 | 2005 | 2 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 698 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3598 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3762 | 0.020 |
Why?
|
Peritonitis | 1 | 2008 | 370 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 575 | 0.020 |
Why?
|
Phagocytes | 1 | 2007 | 296 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5902 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2014 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1993 | 2104 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6375 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8008 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12602 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2009 | 752 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 286 | 0.010 |
Why?
|
Siblings | 1 | 2008 | 825 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1755 | 0.010 |
Why?
|
Ethanol | 1 | 2010 | 1323 | 0.010 |
Why?
|
Binding Sites | 1 | 1993 | 6050 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2010 | 1952 | 0.010 |
Why?
|
Hot Temperature | 1 | 2010 | 1435 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5783 | 0.010 |
Why?
|
Decidua | 1 | 2003 | 82 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2007 | 2178 | 0.010 |
Why?
|
Genomics | 1 | 2019 | 5790 | 0.010 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2008 | 621 | 0.010 |
Why?
|
Apoptosis | 2 | 2011 | 9497 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3605 | 0.010 |
Why?
|
Acromioclavicular Joint | 1 | 2004 | 76 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8498 | 0.010 |
Why?
|
Microglia | 1 | 2011 | 1348 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2011 | 1711 | 0.010 |
Why?
|
Allergens | 1 | 2009 | 1399 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 871 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2003 | 1143 | 0.010 |
Why?
|
Learning | 1 | 2011 | 1733 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2006 | 732 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12915 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36247 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1433 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 1694 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13967 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4814 | 0.010 |
Why?
|
Salmonella typhimurium | 1 | 2002 | 344 | 0.010 |
Why?
|
Pedigree | 1 | 2007 | 4577 | 0.010 |
Why?
|
Cysteine | 1 | 2003 | 897 | 0.010 |
Why?
|
Hippocampus | 1 | 2011 | 3737 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3293 | 0.010 |
Why?
|
Protein Transport | 1 | 2002 | 1966 | 0.010 |
Why?
|
Treatment Failure | 1 | 2002 | 2646 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6131 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 5784 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2004 | 1262 | 0.010 |
Why?
|
Transcription Factors | 1 | 2011 | 12100 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9283 | 0.010 |
Why?
|
Rats | 1 | 2003 | 23695 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13629 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2002 | 39254 | 0.000 |
Why?
|